Skip to content
10-Q

Quarterly Report

NEXUS BIOPHARMA INC

0001213900-17-011006

← back to feed
Filed
Oct 27, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Oct 27, 2017 64.3M sh
Cash And Equivalents Q1 2018 · May 31, 2017 $8.43K
Cash And Equivalents Q1 2018 · Feb 28, 2017 $77
Cash And Equivalents Q1 2018 · May 31, 2016 $125.81K
Cash And Equivalents Q1 2018 · Feb 29, 2016 $9.93K
Current Liabilities Q1 2018 · May 31, 2017 $1.82M
Current Liabilities Q1 2018 · Feb 28, 2017 $1.42M
Total Liabilities Q1 2018 · May 31, 2017 $1.87M
Total Liabilities Q1 2018 · Feb 28, 2017 $1.46M
Current Assets Q1 2018 · May 31, 2017 $9.93K
Current Assets Q1 2018 · Feb 28, 2017 $1.08K
Total Assets Q1 2018 · May 31, 2017 $17.9K
Total Assets Q1 2018 · Feb 28, 2017 $9.53K
Sga Expense Q1 2018 · May 31, 2017 $157.45K
Sga Expense Q1 2018 · May 31, 2016 $248.01K
Rd Expense Q1 2018 · May 31, 2017 $7.53K
Rd Expense Q1 2018 · May 31, 2016 $7.5K
Net Income Q1 2018 · May 31, 2017 −$390.2K
Net Income Q1 2018 · May 31, 2016 −$259.66K